Pub Date : 2021-12-01Epub Date: 2021-04-25DOI: 10.1177/1089253221998552
Soheyla Nazarnia, Kathirvel Subramaniam
Opioid analgesia is still considered the standard of practice for cardiac surgery. In recent years, combinations of several nonnarcotic analgesics and regional analgesia have shown promise in restricting opioid use during and after cardiac surgery. Ketamine infusion, dexmedetomidine infusion, acetaminophen, ketorolac, and gabapentin are useful adjuvants in cardiac anesthesia practice and have opioid-sparing properties. The beneficial effects of nonnarcotic multimodal analgesia on intraoperative stress response, recovery profile, postoperative pain, and persistent opioid use after cardiac surgery are yet to be established, and further randomized clinical trials are required.
{"title":"Nonopioid Analgesics in Postoperative Pain Management After Cardiac Surgery.","authors":"Soheyla Nazarnia, Kathirvel Subramaniam","doi":"10.1177/1089253221998552","DOIUrl":"https://doi.org/10.1177/1089253221998552","url":null,"abstract":"<p><p>Opioid analgesia is still considered the standard of practice for cardiac surgery. In recent years, combinations of several nonnarcotic analgesics and regional analgesia have shown promise in restricting opioid use during and after cardiac surgery. Ketamine infusion, dexmedetomidine infusion, acetaminophen, ketorolac, and gabapentin are useful adjuvants in cardiac anesthesia practice and have opioid-sparing properties. The beneficial effects of nonnarcotic multimodal analgesia on intraoperative stress response, recovery profile, postoperative pain, and persistent opioid use after cardiac surgery are yet to be established, and further randomized clinical trials are required.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 4","pages":"280-288"},"PeriodicalIF":1.4,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1089253221998552","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38908772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-04-14DOI: 10.1177/10892532211008742
Rose K McGahan, Jonathan E Tang, Manoj H Iyer, Antolin S Flores, Leonid A Gorelik
In this article, we describe a case of a 33-year-old female with Alagille syndrome complicated by bilateral branch pulmonary artery stenosis resulting in moderate pulmonary hypertension, end-stage liver disease complicated by portal hypertension, and chronic renal disease who presented for combined liver-kidney transplant. Alagille syndrome is an autosomal dominant disease affecting the liver, heart, and kidneys. Multidisciplinary preoperative evaluation was performed with a team consisting of a congenital heart disease cardiologist, a cardiac anesthesiologist, a nephrologist, and a transplant surgeon. We describe Alagille syndrome and our intraoperative management. To our knowledge, this is the first description of a combined liver-kidney transplant in an adult patient with Alagille syndrome.
{"title":"Combined Liver Kidney Transplant in Adult Patient With Alagille Syndrome and Pulmonary Hypertension.","authors":"Rose K McGahan, Jonathan E Tang, Manoj H Iyer, Antolin S Flores, Leonid A Gorelik","doi":"10.1177/10892532211008742","DOIUrl":"https://doi.org/10.1177/10892532211008742","url":null,"abstract":"<p><p>In this article, we describe a case of a 33-year-old female with Alagille syndrome complicated by bilateral branch pulmonary artery stenosis resulting in moderate pulmonary hypertension, end-stage liver disease complicated by portal hypertension, and chronic renal disease who presented for combined liver-kidney transplant. Alagille syndrome is an autosomal dominant disease affecting the liver, heart, and kidneys. Multidisciplinary preoperative evaluation was performed with a team consisting of a congenital heart disease cardiologist, a cardiac anesthesiologist, a nephrologist, and a transplant surgeon. We describe Alagille syndrome and our intraoperative management. To our knowledge, this is the first description of a combined liver-kidney transplant in an adult patient with Alagille syndrome.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"191-195"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10892532211008742","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25608817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-02-05DOI: 10.1177/1089253221991372
Scott R Coleman, Theodore J Cios, Steven Riela, S Michael Roberts
Objectives: To determine if hemodynamic changes secondary to propofol administration are a result of direct myocardial depression as measured by global longitudinal strain (GLS). The authors hypothesized that propofol would cause a significant worsening in GLS, indicating direct myocardial depression.
Design: Prospective, observational.
Setting: Endoscopy suite at a single academic medical center.
Participants: Patients undergoing outpatient, elective endoscopic procedures at an outpatient clinic of a single tertiary care academic medical center.
Interventions: None.
Measurements and main results: Limited transthoracic echocardiograms were performed before and after patients received propofol for endoscopic procedures. Post-processing measurements included GLS, 2D (dimensional) ejection fraction (2D EF), and 3D EF. Using paired sample Student's t test, no statistically significant change in GLS, 2D EF, or 3D EF was found despite statistically significant hypotension. In fact, there was a trend toward more negative GLS (improved myocardial function) in patients after receiving propofol.
Conclusion: We found propofol did not cause a reduction in systolic function as measured by GLS, a sensitive measure of myocardial contractility. Therefore, decreases in blood pressure after a propofol bolus in spontaneously breathing patients are likely due to decreased vascular tone and not impaired left ventricular systolic function. These results should be considered in the management of propofol-induced hypotension for spontaneously breathing patients.
{"title":"The Effects of Propofol on Left Ventricular Global Longitudinal Strain.","authors":"Scott R Coleman, Theodore J Cios, Steven Riela, S Michael Roberts","doi":"10.1177/1089253221991372","DOIUrl":"https://doi.org/10.1177/1089253221991372","url":null,"abstract":"<p><strong>Objectives: </strong>To determine if hemodynamic changes secondary to propofol administration are a result of direct myocardial depression as measured by global longitudinal strain (GLS). The authors hypothesized that propofol would cause a significant worsening in GLS, indicating direct myocardial depression.</p><p><strong>Design: </strong>Prospective, observational.</p><p><strong>Setting: </strong>Endoscopy suite at a single academic medical center.</p><p><strong>Participants: </strong>Patients undergoing outpatient, elective endoscopic procedures at an outpatient clinic of a single tertiary care academic medical center.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>Limited transthoracic echocardiograms were performed before and after patients received propofol for endoscopic procedures. Post-processing measurements included GLS, 2D (dimensional) ejection fraction (2D EF), and 3D EF. Using paired sample Student's <i>t</i> test, no statistically significant change in GLS, 2D EF, or 3D EF was found despite statistically significant hypotension. In fact, there was a trend toward more negative GLS (improved myocardial function) in patients after receiving propofol.</p><p><strong>Conclusion: </strong>We found propofol did not cause a reduction in systolic function as measured by GLS, a sensitive measure of myocardial contractility. Therefore, decreases in blood pressure after a propofol bolus in spontaneously breathing patients are likely due to decreased vascular tone and not impaired left ventricular systolic function. These results should be considered in the management of propofol-induced hypotension for spontaneously breathing patients.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"185-190"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1089253221991372","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25334574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2020-12-24DOI: 10.1177/1089253220982202
Nicolas Kumar, Julia E Kumar, Nasir Hussain, Leonid Gorelik, Michael K Essandoh, Bryan A Whitson, Amar M Bhatt, Antolin S Flores, Ali Hachem, Tamara R Sawyer, Manoj H Iyer
Background: New or worsened mitral regurgitation (MR) is an uncommon yet serious complication after surgical aortic valve replacement (SAVR). While there have been numerous reports of its occurrence, there is little consensus regarding its presentation and management. This systematic review summarizes the evidence in the current literature surrounding new or worsened MR after SAVR and analyzes its potential implications.
Methods: Databases were examined for all articles and abstracts reporting on new or worsened MR after SAVR. Data collected included number of patients studied; patient characteristics; incidences of new or worsened MR; timing of diagnosis; and treatment.
Results: Thirty-six full-text citations were included in this review. The prevalence of new or worsened MR after SAVR was 8.4%. Sixteen percent of new MR occurrences were from an organic etiology, and 83% of new MR occurrences were that of a functional etiology. Most diagnoses were made in the late or unspecified postoperative period using echocardiography (range: 0 minutes to 18 years postoperatively). While no patients died from this complication, 7.7% of patients (16 out of 207) required emergent procedural re-intervention.
Conclusions: This systematic review underscores the importance of identifying new or worsened MR following SAVR and accurate scoring of MR severity to guide treatment. It also outlines the associated clinical measures commonly documented following this complication, and the usefulness of transesophageal echocardiography for the detection of significant MR. These results reflect the current, limited state of the literature on this topic and warrant further investigation into MR detection and management strategies in SAVR patients.
{"title":"New or Worsened Mitral Regurgitation After Surgical Aortic Valve Replacement: A Systematic Review.","authors":"Nicolas Kumar, Julia E Kumar, Nasir Hussain, Leonid Gorelik, Michael K Essandoh, Bryan A Whitson, Amar M Bhatt, Antolin S Flores, Ali Hachem, Tamara R Sawyer, Manoj H Iyer","doi":"10.1177/1089253220982202","DOIUrl":"https://doi.org/10.1177/1089253220982202","url":null,"abstract":"<p><strong>Background: </strong>New or worsened mitral regurgitation (MR) is an uncommon yet serious complication after surgical aortic valve replacement (SAVR). While there have been numerous reports of its occurrence, there is little consensus regarding its presentation and management. This systematic review summarizes the evidence in the current literature surrounding new or worsened MR after SAVR and analyzes its potential implications.</p><p><strong>Methods: </strong>Databases were examined for all articles and abstracts reporting on new or worsened MR after SAVR. Data collected included number of patients studied; patient characteristics; incidences of new or worsened MR; timing of diagnosis; and treatment.</p><p><strong>Results: </strong>Thirty-six full-text citations were included in this review. The prevalence of new or worsened MR after SAVR was 8.4%. Sixteen percent of new MR occurrences were from an organic etiology, and 83% of new MR occurrences were that of a functional etiology. Most diagnoses were made in the late or unspecified postoperative period using echocardiography (range: 0 minutes to 18 years postoperatively). While no patients died from this complication, 7.7% of patients (16 out of 207) required emergent procedural re-intervention.</p><p><strong>Conclusions: </strong>This systematic review underscores the importance of identifying new or worsened MR following SAVR and accurate scoring of MR severity to guide treatment. It also outlines the associated clinical measures commonly documented following this complication, and the usefulness of transesophageal echocardiography for the detection of significant MR. These results reflect the current, limited state of the literature on this topic and warrant further investigation into MR detection and management strategies in SAVR patients.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"173-184"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1089253220982202","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38746234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-04-25DOI: 10.1177/10892532211007259
Faisal D Arain, Victoria A Gilbride
Pulmonary artery aneurysm (PAA) is a rare disorder that may be classified as congenital, acquired, or idiopathic, in the case of unclear etiology. When associated with severe idiopathic pulmonary arterial hypertension, such a case of PAA may present to the operating room as an indication for lung transplantation. In this article, we present such a case of a patient with a giant main and right PAA that underwent a double lung transplant. We describe the pathophysiology and natural course of this PAA and discuss the role of intraoperative transesophageal echocardiography in the management of patients with this rare diagnosis.
{"title":"Pulmonary Artery Aneurysm Associated With Severe Pulmonary Hypertension in a Patient Presenting for Double Lung Transplant: Review of a Rare Disorder and Role of Transesophageal Echocardiography.","authors":"Faisal D Arain, Victoria A Gilbride","doi":"10.1177/10892532211007259","DOIUrl":"https://doi.org/10.1177/10892532211007259","url":null,"abstract":"<p><p>Pulmonary artery aneurysm (PAA) is a rare disorder that may be classified as congenital, acquired, or idiopathic, in the case of unclear etiology. When associated with severe idiopathic pulmonary arterial hypertension, such a case of PAA may present to the operating room as an indication for lung transplantation. In this article, we present such a case of a patient with a giant main and right PAA that underwent a double lung transplant. We describe the pathophysiology and natural course of this PAA and discuss the role of intraoperative transesophageal echocardiography in the management of patients with this rare diagnosis.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"164-172"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10892532211007259","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38829764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-03-16DOI: 10.1177/1089253221998546
Dash F T Newington, Fabrizio De Rita, Alan McCheyne, Claire Louise Barker
Background: Ventricular assist devices (VADs) are increasingly being implanted in children, yet there is little literature to guide anesthetic management for these procedures.
Aims: To describe the pediatric population presenting for VAD implantation and the anesthetic management these patients receive. To compare (a) children under and over 12 months of age and (b) children with and without congenital heart disease.
Methods: Retrospective review of patients aged 0 to 17 years who underwent VAD implantation at a single center between 2014 and 2019.
Results: Seventy-seven VADs were implanted in 68 patients (46 left VADs, 24 biventricular VADs, 6 right VADs, and 1 univentricular VAD). One procedure was abandoned. Preoperatively, 20 (26%) patients were supported with extracorporeal membrane oxygenation and 57 (73%) patients were ventilated. Intraoperative donor blood products were required in 74 (95%) cases. Postimplantation inotropic support was required in 66 (85%) cases overall and 46 (100%) patients receiving a left VAD. Infants under 12 months were more likely to require preoperative extracorporeal membrane oxygenation (42% vs 19%), have femoral venous access (54% vs 28%), receive an intraoperative vasoconstrictor (42% vs 24%), and have delayed sternal closure (63 vs 22%). Mortality was higher in patients under 12 months (25% vs 19%) and in patients with congenital heart disease (25% vs 20%).
Conclusions: Children undergoing VAD implantation require high levels of preoperative organ support, high-dose intraoperative inotropic support, and high-volume blood transfusion. Children under 12 months and those with congenital heart disease are particularly challenging for anesthesiologists and have worse overall outcomes.
背景:心室辅助装置(VADs)越来越多地被植入儿童,但很少有文献指导这些手术的麻醉管理。目的:描述以VAD植入术为临床表现的儿科患者以及这些患者接受的麻醉处理。比较(a) 12个月以下和12个月以上的儿童和(b)患有和不患有先天性心脏病的儿童。方法:回顾性分析2014年至2019年在单一中心接受VAD植入的0 ~ 17岁患者。结果:68例患者共植入77个VAD,其中左室VAD 46个,双室VAD 24个,右室VAD 6个,单室VAD 1个。一个程序被放弃了。术前20例(26%)患者采用体外膜氧合,57例(73%)患者采用通气。74例(95%)患者需要术中供血制品。66例(85%)植入后需要肌力支持,46例(100%)左侧VAD患者需要肌力支持。12个月以下的婴儿更有可能需要术前体外膜氧合(42%对19%),有股静脉通道(54%对28%),术中接受血管收缩剂(42%对24%),以及延迟胸骨闭合(63%对22%)。12个月以下的患者死亡率更高(25% vs 19%),先天性心脏病患者死亡率更高(25% vs 20%)。结论:接受VAD植入的儿童术前需要高水平的器官支持,术中需要大剂量的肌力支持和大容量输血。12个月以下的儿童和患有先天性心脏病的儿童对麻醉师来说尤其具有挑战性,总体结果也更差。
{"title":"Pediatric Ventricular Assist Device Implantation: An Anesthesia Perspective.","authors":"Dash F T Newington, Fabrizio De Rita, Alan McCheyne, Claire Louise Barker","doi":"10.1177/1089253221998546","DOIUrl":"https://doi.org/10.1177/1089253221998546","url":null,"abstract":"<p><strong>Background: </strong>Ventricular assist devices (VADs) are increasingly being implanted in children, yet there is little literature to guide anesthetic management for these procedures.</p><p><strong>Aims: </strong>To describe the pediatric population presenting for VAD implantation and the anesthetic management these patients receive. To compare (a) children under and over 12 months of age and (b) children with and without congenital heart disease.</p><p><strong>Methods: </strong>Retrospective review of patients aged 0 to 17 years who underwent VAD implantation at a single center between 2014 and 2019.</p><p><strong>Results: </strong>Seventy-seven VADs were implanted in 68 patients (46 left VADs, 24 biventricular VADs, 6 right VADs, and 1 univentricular VAD). One procedure was abandoned. Preoperatively, 20 (26%) patients were supported with extracorporeal membrane oxygenation and 57 (73%) patients were ventilated. Intraoperative donor blood products were required in 74 (95%) cases. Postimplantation inotropic support was required in 66 (85%) cases overall and 46 (100%) patients receiving a left VAD. Infants under 12 months were more likely to require preoperative extracorporeal membrane oxygenation (42% vs 19%), have femoral venous access (54% vs 28%), receive an intraoperative vasoconstrictor (42% vs 24%), and have delayed sternal closure (63 vs 22%). Mortality was higher in patients under 12 months (25% vs 19%) and in patients with congenital heart disease (25% vs 20%).</p><p><strong>Conclusions: </strong>Children undergoing VAD implantation require high levels of preoperative organ support, high-dose intraoperative inotropic support, and high-volume blood transfusion. Children under 12 months and those with congenital heart disease are particularly challenging for anesthesiologists and have worse overall outcomes.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"229-238"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1089253221998546","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25482528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-01-04DOI: 10.1177/1089253220982183
Cynthia Williams, Erin Stewart, Kendra D Conzen, Scott Wolf, Timothy T Tran
There are limited data to guide the use of anticoagulation in cirrhotic patients prior to liver transplantation especially when using direct oral anticoagulants. In this article, we present 2 cases. The first is a 42-year-old male with cirrhosis complicated by portal vein thrombosis (PVT) treated with dabigatran who underwent orthotopic liver transplantation without complication. The second case is a 65-year-old man with alcoholic cirrhosis complicated by PVT treated with dabigatran who underwent orthotopic liver transplantation and required reoperation for surgical bleeding. Both patients were treated with dabigatran's reversal agent idarucizumab prior to incision. In this case series, we discuss the treatment of cirrhotic patients with various anticoagulants, considerations for anticoagulant selection and reversal prior to liver transplant, and questions for future investigation.
{"title":"Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation.","authors":"Cynthia Williams, Erin Stewart, Kendra D Conzen, Scott Wolf, Timothy T Tran","doi":"10.1177/1089253220982183","DOIUrl":"https://doi.org/10.1177/1089253220982183","url":null,"abstract":"<p><p>There are limited data to guide the use of anticoagulation in cirrhotic patients prior to liver transplantation especially when using direct oral anticoagulants. In this article, we present 2 cases. The first is a 42-year-old male with cirrhosis complicated by portal vein thrombosis (PVT) treated with dabigatran who underwent orthotopic liver transplantation without complication. The second case is a 65-year-old man with alcoholic cirrhosis complicated by PVT treated with dabigatran who underwent orthotopic liver transplantation and required reoperation for surgical bleeding. Both patients were treated with dabigatran's reversal agent idarucizumab prior to incision. In this case series, we discuss the treatment of cirrhotic patients with various anticoagulants, considerations for anticoagulant selection and reversal prior to liver transplant, and questions for future investigation.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"200-207"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1089253220982183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38777028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01DOI: 10.1177/10892532211038779
Benjamin Abrams, Gregory J Latham, Miklos D Kertai, Nathaen Weitzel
The COVID-19 pandemic has presented significant challenges to many forms of research and other scholarly activity. Patient enrollment has been hampered, collaboration among coinvestigators and coauthors has been difficult, and simply the allotted time to pursue research and academic projects during the strain of the pandemic on clinical and family life has been a significant hurdle. However, many groups have managed to overcome these obstacles and continued to produce important work across a broad range of subspecialties within the field of anesthesiology. This issue of Seminars in Cardiothoracic and Vascular Anesthesia highlights the impressive dedication and fortitude of those who have managed to overcome the pandemic in this regard. The work includes review articles on pulmonary artery aneurysm (PAA) and mitral regurgitation (MR) following surgical aortic valve replacement (SAVR), an original research article investigating the direct myocardial effects of propofol, as well as 2 separate forums in abdominal transplantation and congenital cardiac diseases. The first of 2 articles in the Reviews section of the journal offers a thorough discussion of PAA. Here, Drs Arain and Gilbride1 describe a unique case of a patient with PAA secondary to severe pulmonary hypertension presenting for double lung transplantation. They include impressive intraoperative transesophageal echocardiography images along with a description of the successful perioperative management of this patient. The authors then go on to provide a thorough description of the etiology, pathophysiology, and various imaging modalities for assessment of PAA. They provide a discussion of the various treatment options for PAA, including surgical repair and lung transplant, depending on the etiology. They also highlight the unique anesthetic considerations for these patients intraoperatively, including specific approaches to ventilator management as well as hemodynamic considerations in order to avoid catastrophic rupture of the PAA. Kumar et al2 produced the second article in the Reviews section, providing a thorough evaluation of the literature with regard to new or worsened MR following SAVR. The group identified 36 full-text citations describing this specific complication of SAVR, representing 207 patients. As the primary outcome of their work, they estimated the prevalence of new or worsened MR after SAVR to be 8.4%. They went on to classify unique subgroups by the specific mechanism of MR: extravalvular (prosthetic aortic valve components or sutures interfering with mitral valve function), intravalvular (Manouguian patch degeneration or iatrogenic injury), and various forms of functional MR. Interestingly, the vast majority of cases were not identified intraoperatively or even within the first 48 hours postoperatively. Functional MR was by far the most commonly reported mechanism, including both systolic anterior motion of the mitral valve and left ventricular dysfunction. Consistent w
{"title":"Continuing Research in the Face of Adversity.","authors":"Benjamin Abrams, Gregory J Latham, Miklos D Kertai, Nathaen Weitzel","doi":"10.1177/10892532211038779","DOIUrl":"https://doi.org/10.1177/10892532211038779","url":null,"abstract":"The COVID-19 pandemic has presented significant challenges to many forms of research and other scholarly activity. Patient enrollment has been hampered, collaboration among coinvestigators and coauthors has been difficult, and simply the allotted time to pursue research and academic projects during the strain of the pandemic on clinical and family life has been a significant hurdle. However, many groups have managed to overcome these obstacles and continued to produce important work across a broad range of subspecialties within the field of anesthesiology. This issue of Seminars in Cardiothoracic and Vascular Anesthesia highlights the impressive dedication and fortitude of those who have managed to overcome the pandemic in this regard. The work includes review articles on pulmonary artery aneurysm (PAA) and mitral regurgitation (MR) following surgical aortic valve replacement (SAVR), an original research article investigating the direct myocardial effects of propofol, as well as 2 separate forums in abdominal transplantation and congenital cardiac diseases. The first of 2 articles in the Reviews section of the journal offers a thorough discussion of PAA. Here, Drs Arain and Gilbride1 describe a unique case of a patient with PAA secondary to severe pulmonary hypertension presenting for double lung transplantation. They include impressive intraoperative transesophageal echocardiography images along with a description of the successful perioperative management of this patient. The authors then go on to provide a thorough description of the etiology, pathophysiology, and various imaging modalities for assessment of PAA. They provide a discussion of the various treatment options for PAA, including surgical repair and lung transplant, depending on the etiology. They also highlight the unique anesthetic considerations for these patients intraoperatively, including specific approaches to ventilator management as well as hemodynamic considerations in order to avoid catastrophic rupture of the PAA. Kumar et al2 produced the second article in the Reviews section, providing a thorough evaluation of the literature with regard to new or worsened MR following SAVR. The group identified 36 full-text citations describing this specific complication of SAVR, representing 207 patients. As the primary outcome of their work, they estimated the prevalence of new or worsened MR after SAVR to be 8.4%. They went on to classify unique subgroups by the specific mechanism of MR: extravalvular (prosthetic aortic valve components or sutures interfering with mitral valve function), intravalvular (Manouguian patch degeneration or iatrogenic injury), and various forms of functional MR. Interestingly, the vast majority of cases were not identified intraoperatively or even within the first 48 hours postoperatively. Functional MR was by far the most commonly reported mechanism, including both systolic anterior motion of the mitral valve and left ventricular dysfunction. Consistent w","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"161-163"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01DOI: 10.1177/10892532211027395
Casey A Quinlan, Gregory J Latham, Denise Joffe, Faith J Ross
Tetralogy of Fallot with pulmonary atresia (ToF-PA) is a rare diagnosis that includes an extraordinarily heterogeneous group of complex anatomical findings with significant implications for physiology and prognosis. In addition to the classic findings of ToF, this particular diagnosis is characterized by complete failure of forward flow from the right ventricle to the pulmonary arterial system. As such, pulmonary blood flow is entirely dependent on shunting from the systemic circulation, most frequently via a patent ductus arteriosus, major aortopulmonary collaterals, or a combination of the two. The pathophysiology of ToF-PA is largely attributable to the abnormalities of the pulmonary vasculature. Ultimately, these patients require operative intervention to create a reliable, controlled source of pulmonary blood flow and ideally complete intracardiac repair. Even after operative correction, these patients remain at risk for pulmonary arterial stenoses and pulmonary hypertension. Although there have been significant advances in surgical and interventional management of ToF-PA leading to dramatic improvements in survival and long-term functional status, there is ongoing debate about the optimal management strategy given the risk of development of irreversible abnormalities of the pulmonary vasculature and the morbidity and mortality associated with sometimes multiple, complex operative interventions often occurring early in infancy. This review will discuss the findings in patients with ToF-PA with a focus on the perioperative and anesthetic management and will highlight challenges faced by the anesthesiologist in caring for these patients.
{"title":"Perioperative and Anesthetic Considerations in Tetralogy of Fallot With Pulmonary Atresia.","authors":"Casey A Quinlan, Gregory J Latham, Denise Joffe, Faith J Ross","doi":"10.1177/10892532211027395","DOIUrl":"https://doi.org/10.1177/10892532211027395","url":null,"abstract":"<p><p>Tetralogy of Fallot with pulmonary atresia (ToF-PA) is a rare diagnosis that includes an extraordinarily heterogeneous group of complex anatomical findings with significant implications for physiology and prognosis. In addition to the classic findings of ToF, this particular diagnosis is characterized by complete failure of forward flow from the right ventricle to the pulmonary arterial system. As such, pulmonary blood flow is entirely dependent on shunting from the systemic circulation, most frequently via a patent ductus arteriosus, major aortopulmonary collaterals, or a combination of the two. The pathophysiology of ToF-PA is largely attributable to the abnormalities of the pulmonary vasculature. Ultimately, these patients require operative intervention to create a reliable, controlled source of pulmonary blood flow and ideally complete intracardiac repair. Even after operative correction, these patients remain at risk for pulmonary arterial stenoses and pulmonary hypertension. Although there have been significant advances in surgical and interventional management of ToF-PA leading to dramatic improvements in survival and long-term functional status, there is ongoing debate about the optimal management strategy given the risk of development of irreversible abnormalities of the pulmonary vasculature and the morbidity and mortality associated with sometimes multiple, complex operative interventions often occurring early in infancy. This review will discuss the findings in patients with ToF-PA with a focus on the perioperative and anesthetic management and will highlight challenges faced by the anesthesiologist in caring for these patients.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"218-228"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-01Epub Date: 2021-04-12DOI: 10.1177/10892532211007270
Vittorio Cherchi, Umberto Baccarani, Luigi Vetrugno, Riccardo Pravisani, Tiziana Bove, Francesco Meroi, Giovanni Terrosu, Gian Luigi Adani
The shortage of organs and the growing need for them over recent years have led to the adoption of less stringent donor acceptance criteria, resulting in the approval of marginal organs for transplant, especially from elderly donors. This implies a higher risk of graft dysfunction, a higher frequency of immunological and vascular complications, and shorter graft survival. Several strategies have been implemented in clinical practice to assess graft quality and suitability for transplantation. We have started to test the prospective intraoperative use of thermo-vision cameras during graft reperfusion. Images were acquired using the FLIR One Pro thermo-vision camera for android devices. We hypothesized that thermal images would give a better perspective about the quality of arterial perfusion and graft revascularization of the renal cortex. Thermo-vision cameras provide an easy-to-use, noninvasive, cost-effective tool for the global assessment of kidney graft cortical microcirculation in the immediate post-reperfusion period, providing additional data on the immediate viability and function of a graft.
器官短缺和近年来对器官的需求日益增长,导致采用了不那么严格的供体接受标准,从而批准了边缘器官的移植,特别是来自老年供体的移植。这意味着移植物功能障碍的风险更高,免疫和血管并发症的频率更高,移植物存活时间更短。在临床实践中已经实施了几种策略来评估移植物的质量和移植的适宜性。我们已经开始在移植物再灌注过程中测试热视觉摄像机在术中应用的前景。图像采集使用FLIR One Pro热视觉相机用于android设备。我们假设热图像可以更好地了解肾皮质动脉灌注和移植物血运重建的质量。热视觉摄像机提供了一种易于使用、无创、成本效益高的工具,用于在再灌注后立即全面评估肾移植物皮质微循环,为移植物的即时生存能力和功能提供了额外的数据。
{"title":"Early Graft Dysfunction Following Kidney Transplantation: Can Thermographic Imaging Play a Predictive Role?","authors":"Vittorio Cherchi, Umberto Baccarani, Luigi Vetrugno, Riccardo Pravisani, Tiziana Bove, Francesco Meroi, Giovanni Terrosu, Gian Luigi Adani","doi":"10.1177/10892532211007270","DOIUrl":"https://doi.org/10.1177/10892532211007270","url":null,"abstract":"<p><p>The shortage of organs and the growing need for them over recent years have led to the adoption of less stringent donor acceptance criteria, resulting in the approval of marginal organs for transplant, especially from elderly donors. This implies a higher risk of graft dysfunction, a higher frequency of immunological and vascular complications, and shorter graft survival. Several strategies have been implemented in clinical practice to assess graft quality and suitability for transplantation. We have started to test the prospective intraoperative use of thermo-vision cameras during graft reperfusion. Images were acquired using the FLIR One Pro thermo-vision camera for android devices. We hypothesized that thermal images would give a better perspective about the quality of arterial perfusion and graft revascularization of the renal cortex. Thermo-vision cameras provide an easy-to-use, noninvasive, cost-effective tool for the global assessment of kidney graft cortical microcirculation in the immediate post-reperfusion period, providing additional data on the immediate viability and function of a graft.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"25 3","pages":"196-199"},"PeriodicalIF":1.4,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10892532211007270","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25578317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}